首页> 外文期刊>Journal of Surgical Oncology >Identification of high-risk stage II and stage III colorectal cancer by analysis of MMP-21 expression.
【24h】

Identification of high-risk stage II and stage III colorectal cancer by analysis of MMP-21 expression.

机译:通过分析MMP-21的表达鉴定高危II期和III期结直肠癌。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: The expression of matrix metalloproteinase-21 (MMP-21) has been shown to be elevated in some solid tumor and thought to enhance tumor invasion and metastasis ability. In the present study, we investigated the expression of MMP-21 and its association with prognosis in stage II and III colorectal cancer. METHODS: MMP-21 expression was investigated in 286 cases of colorectal cancer by immunohistochemistry assay. Statistical analysis was utilized to evaluate the association of MMP-21 expression with clinicopathological characters and overall survival of patients with stage II and III colorectal cancer. RESULTS: MMP-21 expression was significantly higher in colorectal cancer, compared with that in normal epithelial tissue. And it also correlated with tumor invasion, lymph node metastasis, and distant metastasis of colorectal cancer. MMP-21 was also proved to be an independent prognostic factor in patients with stage II as well as stage III colorectal cancer. However, no correlations between MMP-21 expression and patients' age, sex, tumor location, or differentiation status were detected. CONCLUSION: These results suggested the potential role of MMP-21 in the invasion and metastasis process of human colorectal cancer. It could also be a novel molecular marker to predict prognosis of patients with stage II and stage III colorectal cancer.
机译:背景:基质金属蛋白酶21(MMP-21)的表达已在某些实体瘤中升高,并被认为可以增强肿瘤的侵袭和转移能力。在本研究中,我们调查了MMP-21的表达及其与II和III期大肠癌预后的关系。方法:采用免疫组织化学方法检测286例大肠癌组织中MMP-21的表达。统计分析用于评估MMP-21表达与II期和III期大肠癌患者的临床病理特征和总体生存率之间的关系。结果:与正常上皮组织相比,MMP-21在大肠癌中的表达明显更高。而且还与大肠癌的肿瘤浸润,淋巴结转移和远处转移有关。 MMP-21还被证明是II期和III期结直肠癌患者的独立预后因素。但是,未检测到MMP-21表达与患者的年龄,性别,肿瘤位置或分化状态之间的相关性。结论:这些结果表明MMP-21在人类大肠癌的侵袭和转移过程中的潜在作用。它也可能是预测II期和III期结直肠癌患者预后的新型分子标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号